This new artificial lens, which can restore sight at near and distant ranges following cataract surgery, has received US FDA and Australian Government TGA approval. Although the PanOptix lens implant is relatively new, there are many thousands already implanted worldwide.
The exceptional visual performance of the PanOptix lens was accomplished by the optics of the lens, without physical movement of the lens inside the eye, making visual outcomes highly predictable.
The clinical studies supporting it showed that over 95% of patients who received the Aspheric PanOptix multifocal lens did not use glasses for any activities after lens replacement surgery.
This is the first time this level of spectacle independence has been achieved.